Introduction

As a consequence of the extensive use of cesarean sections, the incidence of placenta accreta spectrum (PAS) disorders, characterized by abnormal invasion of trophoblastic tissue through the myometrium and uterine serosa, has been growing considerably1. This condition exposes mothers to the risk of massive bleeding (average blood loss ~2-5 L2) and death. The maternal mortality rate in its most severe form (placenta percreta) is reportedly 7%3.
The most recent guidelines4 suggest producing in-hospital protocols that are shared among all involved professionals and establishing a step-by-step plan, from ultrasound-based detection of placenta previa to post-surgery management.